Archive for November 16th, 2008

FDA Issues Early Communication About Ongoing Safety Review of Vytorin, Zocor and Zetia

Sunday, November 16th, 2008

Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia)
FDA Investigates a Report from the SEAS Trial

This information reflects FDA’s current analysis of available data concerning these drugs. Posting this…